Innoviva Historical Balance Sheet

INVA Stock  USD 17.55  0.10  0.57%   
Trend analysis of Innoviva balance sheet accounts such as Other Assets of 131.6 M or Common Stock Shares Outstanding of 81.9 M provides information on Innoviva's total assets, liabilities, and equity, which is the actual value of Innoviva to its prevalent stockholders. By breaking down trends over time using Innoviva balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Innoviva latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Innoviva is a good buy for the upcoming year.

Innoviva Inventory

42.77 Million

  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

About Innoviva Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Innoviva at a specified time, usually calculated after every quarter, six months, or one year. Innoviva Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Innoviva and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Innoviva currently owns. An asset can also be divided into two categories, current and non-current.

Innoviva Balance Sheet Chart

At present, Innoviva's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 708.7 M, whereas Retained Earnings are forecasted to decline to (26.4 M).

Total Assets

Total assets refers to the total amount of Innoviva assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Innoviva books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Innoviva balance sheet. This account contains Innoviva investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Innoviva fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most accounts from Innoviva's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 708.7 M, whereas Retained Earnings are forecasted to decline to (26.4 M).
 2021 2022 2023 2024 (projected)
Total Liabilities400.5M665.7M568.6M442.4M
Other Stockholder Equity870.2M770.0M699.5M1.0B

Innoviva balance sheet Correlations

0.840.710.390.09-0.190.180.130.160.030.34-0.36-0.05-0.120.290.680.97-0.180.090.270.68-0.050.860.020.26-0.36
0.840.860.46-0.3-0.37-0.37-0.410.260.230.340.080.12-0.620.420.580.78-0.57-0.440.330.51-0.380.81-0.450.220.08
0.710.860.46-0.58-0.77-0.36-0.37-0.050.080.440.20.0-0.540.260.470.72-0.44-0.42-0.060.49-0.710.64-0.220.080.2
0.390.460.460.04-0.33-0.21-0.07-0.41-0.49-0.09-0.3-0.3-0.27-0.480.490.43-0.24-0.09-0.210.74-0.220.33-0.150.66-0.3
0.09-0.3-0.580.040.770.70.7-0.07-0.39-0.25-0.86-0.250.65-0.290.130.080.510.730.110.330.92-0.060.360.4-0.86
-0.19-0.37-0.77-0.330.770.330.280.320.04-0.32-0.40.110.350.08-0.19-0.260.20.340.43-0.180.92-0.14-0.040.11-0.4
0.18-0.37-0.36-0.210.70.330.97-0.11-0.28-0.03-0.72-0.280.92-0.240.140.230.760.97-0.10.180.6-0.030.870.05-0.72
0.13-0.41-0.37-0.070.70.280.97-0.23-0.42-0.2-0.75-0.420.93-0.450.210.180.810.99-0.170.230.56-0.120.910.14-0.75
0.160.26-0.05-0.41-0.070.32-0.11-0.230.910.190.40.47-0.250.680.06-0.01-0.39-0.250.78-0.410.090.32-0.32-0.320.4
0.030.230.08-0.49-0.390.04-0.28-0.420.910.30.680.55-0.380.79-0.1-0.11-0.47-0.440.6-0.56-0.20.24-0.35-0.470.68
0.340.340.44-0.09-0.25-0.32-0.03-0.20.190.30.150.49-0.230.450.090.34-0.42-0.230.060.09-0.330.55-0.15-0.340.15
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.150.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.471.0
-0.050.120.0-0.3-0.250.11-0.28-0.420.470.550.490.44-0.40.5-0.07-0.13-0.46-0.410.45-0.47-0.060.18-0.41-0.090.44
-0.12-0.62-0.54-0.270.650.350.920.93-0.25-0.38-0.23-0.64-0.4-0.4-0.16-0.030.850.95-0.330.040.59-0.30.88-0.03-0.64
0.290.420.26-0.48-0.290.08-0.24-0.450.680.790.450.450.5-0.4-0.130.21-0.5-0.450.44-0.29-0.070.46-0.43-0.410.45
0.680.580.470.490.13-0.190.140.210.06-0.10.09-0.31-0.07-0.16-0.130.59-0.090.150.420.51-0.070.490.090.43-0.31
0.970.780.720.430.08-0.260.230.18-0.01-0.110.34-0.41-0.13-0.030.210.59-0.10.150.050.73-0.070.830.110.26-0.41
-0.18-0.57-0.44-0.240.510.20.760.81-0.39-0.47-0.42-0.57-0.460.85-0.5-0.09-0.10.82-0.330.050.46-0.540.820.17-0.57
0.09-0.44-0.42-0.090.730.340.970.99-0.25-0.44-0.23-0.78-0.410.95-0.450.150.150.82-0.180.220.61-0.140.890.14-0.78
0.270.33-0.06-0.210.110.43-0.1-0.170.780.60.060.150.45-0.330.440.420.05-0.33-0.18-0.220.240.33-0.34-0.030.15
0.680.510.490.740.33-0.180.180.23-0.41-0.560.09-0.67-0.470.04-0.290.510.730.050.22-0.220.040.480.080.53-0.67
-0.05-0.38-0.71-0.220.920.920.60.560.09-0.2-0.33-0.67-0.060.59-0.07-0.07-0.070.460.610.240.04-0.130.250.26-0.67
0.860.810.640.33-0.06-0.14-0.03-0.120.320.240.55-0.120.18-0.30.460.490.83-0.54-0.140.330.48-0.13-0.22-0.04-0.12
0.02-0.45-0.22-0.150.36-0.040.870.91-0.32-0.35-0.15-0.49-0.410.88-0.430.090.110.820.89-0.340.080.25-0.22-0.02-0.49
0.260.220.080.660.40.110.050.14-0.32-0.47-0.34-0.47-0.09-0.03-0.410.430.260.170.14-0.030.530.26-0.04-0.02-0.47
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.151.00.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.47
Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva balance sheet Accounts

201920202021202220232024 (projected)
Total Assets724.8M999.6M926.4M1.2B1.2B1.3B
Total Stockholder Equity313.5M539.9M414.7M565.8M675.0M708.7M
Retained Earnings(946.4M)(722.0M)(456.1M)(204.9M)(25.2M)(26.4M)
Other Assets293.6M657.5M425.2M198.5M228.2M131.6M
Common Stock Shares Outstanding113.4M113.6M94.3M95.2M86.9M81.9M
Liabilities And Stockholders Equity724.8M999.6M926.4M1.2B1.2B1.3B
Other Stockholder Equity1.3B1.3B870.2M770.0M699.5M1.0B
Total Liab382.7M391.7M400.5M665.7M568.6M442.4M
Short Long Term Debt Total377.1M410.5M394.7M637.9M449.1M332.2M
Other Current Liab5.4M6.0M5.7M31.7M17.2M12.9M
Total Current Liabilities5.4M6.1M5.8M38.8M38.1M25.0M
Other Liab586K219K106K84.2M75.8M49.3M
Property Plant And Equipment Net33K28K12K3.4M3.0M2.9M
Net Debt99.0M139.0M193.1M346.8M255.6M192.9M
Accounts Payable10K66K27K2.9M6.7M7.1M
Cash278.1M246.5M201.5M291.0M193.5M138.1M
Non Current Assets Total293.6M657.5M612.7M788.0M899.3M944.3M
Non Currrent Assets Other139.4M214K108K101.9M87.1M68.4M
Long Term Debt377.1M385.5M394.7M540.4M446.2M321.7M
Cash And Short Term Investments350.8M246.5M201.5M291.0M193.5M235.5M
Net Receivables79.4M93.9M110.7M64.1M84.1M88.3M
Common Stock Total Equity1.0M1.0M1.0M696K800.4K857.6K
Short Term Investments72.7M438.3M483.8M403.0M463.5M486.6M
Non Current Liabilities Total377.3M385.6M394.7M626.9M530.4M426.9M
Other Current Assets80.4M95.6M1.4M32.5M25.9M22.6M
Property Plant And Equipment Gross33K28K12K3.4M3.0M2.9M
Total Current Assets431.2M342.1M313.7M443.5M344.2M281.5M
Common Stock1.0M1.0M696K692K633K845.9K
Property Plant Equipment33K28K12K3.4M3.1M2.9M
Inventory(79.4M)(93.9M)(110.7M)55.9M40.7M42.8M
Net Tangible Assets313.5M539.9M414.7M286.2M329.1M345.5M
Noncontrolling Interest In Consolidated Entity152K5.5M67.9M111.2M127.9M134.3M
Retained Earnings Total Equity(1.5B)(1.1B)(722.0M)(456.1M)(524.6M)(550.8M)
Long Term Debt Total574.4M382.9M377.1M385.5M443.3M463.7M
Capital Surpluse1.3B1.3B1.3B1.3B1.1B1.1B
Deferred Long Term Liab139.1M125.3M111.4M97.6M112.2M122.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.8
Revenue Per Share
5.6
Quarterly Revenue Growth
0.331
Return On Assets
0.0937
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.